Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study
Crossref DOI link: https://doi.org/10.1007/s10151-014-1177-1
Published Online: 2014-06-12
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tursi, A.
Elisei, W.
Picchio, M.
Zampaletta, C.
Pelecca, G.
Faggiani, R.
Brandimarte, G.
Text and Data Mining valid from 2014-06-12